Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID

Method for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID

US Patent 8227420 · Granted Jul 24, 2012

Estimated economic value: $276,038,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Scalable coding of video and associated features2025
Methods of treatment of diseases in which IL-13 activity is detrimental using an2024
Methods of treatment of diseases in which IL-13 activity is detrimental using an2024
Sensors and assays for ubiquitin or ubiquitin-like proteins2023
Synthetically functionalized living cells for targeted drug delivery2022
Methods of treatment of diseases in which IL-13 activity is detrimental using an2022
Compounds and methods for treating lupus2022
Spray-coating method with particle alignment control2021
Anti-icing coatings2021
Sensors and assays for ubiquitin or ubiquitin-like proteins2021
BSL2v2c2-Ig polypeptides2020
Anti-fingerprint photocatalytic nanostructure for transparent surfaces2019